ChemoCentryx
CCXI
#3578
Rank
HK$29.31 B
Marketcap
HK$407.54
Share price
0.00%
Change (1 day)
34.67%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: HK$29.31 Billion

On November 25, 2022 ChemoCentryx had a market cap of HK$29.31 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022HK$29.21 B46.94%
2021HK$19.88 B-40.15%
2020HK$33.22 B79.06%
2019HK$18.55 B328.74%
2018HK$4.32 B90.89%
2017HK$2.26 B-17.36%
2016HK$2.74 B-1.11%
2015HK$2.77 B20.52%
2014HK$2.30 B19.53%
2013HK$1.92 B-37.54%
2012HK$3.08 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$5.103 T 17,313.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.224 T 4,076.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$3.965 T 13,429.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.847 T 6,202.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$289.21 B 886.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.584 T 8,716.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$942.17 B 3,114.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$750.44 B 2,460.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$358.82 B 1,124.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel